-+ 0.00%
-+ 0.00%
-+ 0.00%

NEONC TECHNOLOGIES - TO SEEK FDA AGREEMENT ON NEO100-012 PHASE 3 TRIAL DESIGN WITH OVERALL SURVIVAL ENDPOINT

Reuters·11/11/2026 13:00:00

Please log in to view news